Despite the very positive setup facing Amgen as a result of its ongoing and future investments in developing new cardiometabolic medicines for big-ticket indications like obesity and type 2 diabetes, ...
In fact, a 2020 report in the medical journal The Lancet found that 12 controllable risk factors—including lack of exercise, smoking, and underlying conditions like high blood pressure or diabetes—are ...
Sometimes healthcare providers prescribe medications that treat other health conditions, like type 2 diabetes, to help treat obesity, known as "off-label" use. For example, the FDA approved ...